CIDARA THERAPEUTICS, INC. Deferred Offering Costs
CIDARA THERAPEUTICS, INC. had Deferred Offering Costs of $1.50 million as of 2015-03-31, per its 10-Q filed 2015-05-21.
Discontinued › Balance Sheet › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2015-05-21
- 2015-03-31: Deferred Offering Costs $1.50M.
| Period end | Deferred Offering Costs |
|---|---|
| 2015-03-31 | $1.50M 10-Q · filed 2015-05-21 |